The optical networking sector has fallen on hard times lately. Many stocks in this category skyrocketed in 2016 and early 2017, only to come crashing back down.
There is no doubt in my mind that high-speed network equipment and components will be in high demand for many years to come. That’s why I’m salivating over the rock-bottom prices that some of the best names in the industry....More>>>
&l;p&g;&l;img class=&q;size-full wp-image-14049&q; src=&q;http://blogs-images.forbes.com/antoinegara/files/2018/06/0522_strategies-masa-takeda_650x455.jpg?width=960&q; alt=&q;&q; data-height=&q;455&q; data-width=&q;650&q;&g; Masakazu Takeda, PM of the Hennessy Japan Fund, is finding big returns in the land of the rising sun.
Japan has endured a lost decade (or three), but Masakazu Takeda....More>>>
&l;p&g;&l;img class=&q;dam-image getty size-large wp-image-1024561716&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/1024561716/960×0.jpg?fit=scale&q; data-height=&q;540&q; data-width=&q;960&q;&g; (Photo by Hu Weiguo/VCG via Getty Images)
&l;span&g;For over two thousands years, scientists have experimented with ways to capture the energy of the sun. Archimedes in 212....More>>>
On Thursday, spot gold prices rose 0.6 percent to close at $1294.8 per ounce as prices rose to nine month high, dollar at four week low. The dollar index is down more than 9 percent so far this year, set for its biggest annual loss since 2003. That’s helped lift gold nearly 5 percent from a near five – month low of $1,235.92 struck in mid....More>>>
Westpac Banking Corp raised its stake in Edwards Lifesciences (NYSE:EW) by 22.6% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 67,689 shares of the medical research company’s stock after purchasing an additional 12,500 shares during the period. Westpac Banking Corp’s holdings in Edwards Lifesciences were worth $9,444,000 as of its most recent SEC....More>>>
Two more big companies are passing savings from the tax bill along to employees.
Verizon (VZ) said in an internal memo Tuesday that it’s giving 50 shares of restricted stock to full-time employees who aren’t executives. The amount will be calculated based on Verizon’s stock value on February 1.
The company explained that the grant will vest over two years and....More>>>
Shareholders of small biotech firm Neothetics (NASDAQ:NEOT) got burned in a big way when lead candidate LIPO-202 flunked dual phase 3 trials roughly a year ago.
NEOT data by YCharts
LIPO-202 is an injectable formulation of salmeterol xinafoate, a well-known long-acting 2-adrenergic receptor agonist used in several FDA-approved drugs. It was indicated for the reduction of central....More>>>
Our newest recommendation offers consumer-oriented health benefit plans and services for a wide range of customers, explains Nicholas Vardy, editor of Vardy’s Alpha Algorithm.
UnitedHealth Group (UNH) also provides Medicaid plans, health care programs and health services through a network of one million physicians and healthcare professionals at some 6,000 hospitals and other facilities.
Wall Street analysts tend to be a bullish lot, and few have been as bullish as FundStrat’s Thomas Lee, who’s been accused of being a perma-bull. But just as his colleagues seem to be embracing another year of gains, Lee has decided to dial back the optimism. In his 2017 outlook released today, Lee wrote that he expects that S&P 500 to finish the year at 2,275, down a few points from....More>>>
It's truly amazing what a difference 23 years can make.
Back in 1995, not a single state in the U.S. nor either of its neighbors, Canada or Mexico, had legalized marijuana in any capacity. Within the U.S., the war on drugs was still in full swing, with a Gallup survey that year showing s
Many dividend stocks fell out of favor over the past year as rising interest rates turned bonds into more attractive income investments. Yet there are still plenty of high-yielding stocks that are currently trading at discount valuations. Today, three of our Motley Fool investors will share thre
With 43 projects raising $1.2 billion in initial coin offerings since May 1, according to Nick Tomaino's The Control, and with stratospheric returns for so many ICOs -- 82,000% for Ethereum, 56,000% for IOTA, 44,000% for Stratis, 21,000% for Spectrecoin -- it's no surprise that this